Pro-opiomelanocortin (POMC)-derived peptides play a critical role in body weight regulation in the central nervous system. Mice deficient in POMC developed obesity. We sought mutations in the POMC gene in 50 morbidly obese (body mass index 35 -60 kg=m 2 ) Japanese subjects with diabetes by direct sequencing. Apart from two silent mutations (C6982T and C7285T), no other mutations were detected. Frequencies of these mutations were not significantly different between 100 obese subjects and 100 controls. Also, the frequencies did not differ in the subjects with or without diabetes. These results suggest that mutations in the POMC gene are unlikely to be a major factor of obesity or diabetes in Japanese subjects.
Introduction
Obesity is a major cause of diabetes, hypertension and cardiovascular diseases. The pro-opiomelanocortin (POMC) has a diverse array of biological activities in the central nervous system. The a-melanocyte-stimulating hormone (a-MSH) is one of the POMC-derived peptides; it functions to reduce appetite through its specific receptor, (melanocortin-4 receptor (MC4R)) in the hypothalamus. Mice deficient in POMC are obese and the administration of exogenous a-MSH into the mice caused a dramatic reduction in body weight. Two endogenous (Agouti and Agouti-related proteins) and several exogenous antagonists of MC4R have physiological actions leading to obesity. In addition, decreased function of the MC4R caused diabetes in mice. Finally, mutations in the POMC and MC4R genes have been found in association with human obesity. 1 -5 Currently, the a-MSH=MC4R pathway has become a major research focus in the treatment of obesity. 6 In a previous report, we described that most of morbidly obese Japanese did not have any significant mutations in the MC4R gene. 7 The present study was undertaken to test the possibility that mutations in the POMC gene contribute to obesity with diabetes in Japanese subjects.
Methods
We studied 100 severely obese (body mass index (BMI) ! 30 kg=m 2 ) subjects with a family history of obesity (BMI ! 25 kg=m 2 is the criterion of obesity in Japan). There were 50 males and 50 females, 70 of whom had type 2 diabetes. A BMI of 30 kg=m 2 represents the 97 -98th percentile in this population, a level equivalent a BMI of 40 kg=m 2 in Americans (reviewed in Ohshiro et al. 8 Primary mutational analysis of the POMC gene was performed in the 50 most obese subjects, all of whom had a BMI at least 35 kg=m 2 (99.7 -99.8th BMI percentile).
Genomic DNA was extracted from peripheral blood leukocytes. The coding region of the POMC gene was amplified with polymerase chain reaction (PCR) according to a method described previously. 9 PCR products were subjected to direct nucleotide sequencing using BigDye terminator chemistry (Perkin-Elmer) and electrophoresed on an ABI 310 automated DNA sequencer (Perkin-Elmer). The polymorphisms detected subsequently were screened for in the remaining 50 obese subjects and 100 nonobese subjects (BMI < 25 kg=m 2 ) with no evidence of endocrine and metabolic disorders being present. Informed consent to participate in this study was given by all the subjects.
Results and discussion
Aside from two silent mutations, C?T at nucleotide position no. 6982 and C?T at no. 7285 (see Takahashi  et al 10 for numbering of genomic sequences) with allelic frequencies of 0.24 and 0.30, respectively, in the 50 massively obese subjects examined, no other mutations were detected. These two variants were firstly detected in Germans; they were observed concurrently in two of 96 (2.0%) extremely obese subjects but not in 60 healthy underweight subjects. 9 The two polymorphisms are common in Japanese. Their frequency did not differ significantly between the expanded set of 100 obese subjects, which included the initially examined 50 obese subjects, and the 100 controls (Table 1) . Also, the frequency was not significantly different in the 70 obese subjects with diabetes (0.27 and 0.27, respectively) compared with controls.
This study represents the first systematic examination of the POMC gene in Asian obese subjects with diabetes. No biologically significant mutations were detected. Although two silent mutations were detected in the Japanese subjects, they were not associated with obesity or diabetes. This suggests that mutations in the POMC gene are unlikely to be a major cause of obesity or diabetes associated with obesity in Japanese.
